CD58 and Miyoshi myopathy: Besides, MSC ensures MM cell survival, disease progression, and drug resistance having upregulated levels of gene expression of angiogenic and growth factors such as CD40/40L, VCAM-1, ICAM-1, lymphocyte function-associated antigen-3 (LFA-3), and immunomodulated level of cytokines: increased IL-6 and reduced IL-10 [71].